|
93 Companies |
|
118 Products |
|
118 Products |
|
88 Mechanisms of Action |
|
3 Trials |
|
1622 News |
|
| «12...2021222324252627282930...3233» |
- esomeprazole / Generic mfg.
Enrollment open: BRAVO Study for Functional Dyspepsia (clinicaltrials.gov) - Feb 16, 2013
P4, N=130, Recruiting, Sponsor: Chinese University of Hong Kong
Not yet recruiting --> Recruiting
- | New P4 trial: ZAZO: Zinc Sulphate vs. Zinc Amino Acid Chelate (clinicaltrials.gov) - Feb 13, 2013
P4, N=360, Completed, Sponsor: CES University
- | Trial completion: A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation (clinicaltrials.gov) - Feb 12, 2013
P3, N=475, Completed, Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||||| esomeprazole / Generic mfg.
Enrollment change: NEXT1: Efficacy of Esomeprazole in Patients With Frequent Heartburn (clinicaltrials.gov) - Feb 11, 2013
P3, N=340, Completed, Sponsor: AstraZeneca
Recruiting --> Completed N=486 --> 340
- | Trial completion: Comparison of Two Types of Family Therapy in the Treatment of Adolescent Anorexia Nervosa (clinicaltrials.gov) - Feb 6, 2013
P3, N=164, Completed, Sponsor: Stanford University
N=486 --> 340 Active, not recruiting --> Completed
- Trial completion: Management of Nausea and Vomiting Chemotherapy-induced in Normandy (clinicaltrials.gov) - Feb 6, 2013
P=N/A, N=300, Completed, Sponsor: Centre Francois Baclesse
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: Trial of Acupuncture for Reduction of Post-Colectomy Ileus (clinicaltrials.gov) - Feb 5, 2013
P2, N=90, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Completed Active, not recruiting --> Completed
- Trial termination: Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection (clinicaltrials.gov) - Feb 2, 2013
P2, N=2, Terminated, Sponsor: Salient Pharmaceuticals Incorporated
Active, not recruiting --> Completed Recruiting --> Terminated; Study was stopped for slow enrollment - only 2 patients, no evaluable results
- Enrollment change: Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection (clinicaltrials.gov) - Feb 2, 2013
P2, N=2, Terminated, Sponsor: Salient Pharmaceuticals Incorporated
Recruiting --> Terminated; Study was stopped for slow enrollment - only 2 patients, no evaluable results N=10 --> 2
- Avastin (bevacizumab) / Roche
Biomarker, Enrollment closed: Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy (clinicaltrials.gov) - Jan 31, 2013
P1, N=76, Active, not recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center
N=10 --> 2 Recruiting --> Active, not recruiting
- || Enrollment change: GERD Q NIS: Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt (clinicaltrials.gov) - Jan 30, 2013
P=N/A, N=3000, Recruiting, Sponsor: AstraZeneca
Recruiting --> Active, not recruiting N=2000 --> 3000
- New P4 trial, Combination therapy: Prophylactic Subhypnotic Propofol for Nausea and Vomiting During for Cesarean Section Under Subarachnoid Anesthesia. (clinicaltrials.gov) - Jan 30, 2013
P4, N=28, Completed, Sponsor: G. d'Annunzio University
- ||| Enrollment open: GERD Q NIS: Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt (clinicaltrials.gov) - Jan 30, 2013
P=N/A, N=3000, Recruiting, Sponsor: AstraZeneca
N=2000 --> 3000 Not yet recruiting --> Recruiting
- || Enrollment closed: Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic (clinicaltrials.gov) - Jan 30, 2013
P=N/A, N=60, Active, not recruiting, Sponsor: The University of Texas Health Science Center, Houston
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial withdrawal: Nurse-Provided Care or Standard Care in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer (clinicaltrials.gov) - Jan 29, 2013
P=N/A, N=0, Withdrawn, Sponsor: City of Hope Medical Center
Recruiting --> Active, not recruiting Completed --> Withdrawn
- Enrollment change: Nurse-Provided Care or Standard Care in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer (clinicaltrials.gov) - Jan 29, 2013
P=N/A, N=0, Withdrawn, Sponsor: City of Hope Medical Center
Completed --> Withdrawn N=100 --> 0
- |||||||||| Hydexor (promethazine/hydrocodone/acetaminophen) / Daiichi Sankyo, Charleston Labs
New P3 trial: Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain (clinicaltrials.gov) - Jan 29, 2013
P3, N=810, Recruiting, Sponsor: Charleston Laboratories, Inc
- | relamorelin (RM-131) / AbbVie
New P2 trial, P2 data: Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation (clinicaltrials.gov) - Jan 29, 2013
P2, N=48, Recruiting, Sponsor: Rhythm Pharmaceuticals, Inc.
- | Relistor (methylnaltrexone bromide) / Ono Pharma, Bausch Health
New P4 trial: Methylnaltrexone Use for Opioid-induced Postoperative Constipation (clinicaltrials.gov) - Jan 21, 2013
P4, N=60, Recruiting, Sponsor: Shriners Hospitals for Children
- cyclophosphamide / Generic mfg.
Trial termination: Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients (clinicaltrials.gov) - Jan 21, 2013
P3, N=580, Terminated, Sponsor: S. Maria Hospital, Terni
N=100 --> 0 Recruiting --> Terminated; We terminated the study after enrolling 580/900 patients due to a slow accrual
- || Amitiza (lubiprostone) / Takeda, Mallinckrodt
Trial initiation date: Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation (clinicaltrials.gov) - Jan 21, 2013
P=N/A, N=60, Completed, Sponsor: University of Michigan
Recruiting --> Terminated; We terminated the study after enrolling 580/900 patients due to a slow accrual Initiation date: Aug 2010 --> Nov 2010
- cyclophosphamide / Generic mfg.
Enrollment change: Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients (clinicaltrials.gov) - Jan 21, 2013
P3, N=580, Terminated, Sponsor: S. Maria Hospital, Terni
Initiation date: Aug 2010 --> Nov 2010 N=800 --> 580
- ||| Amitiza (lubiprostone) / Takeda, Mallinckrodt
Trial completion: Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation (clinicaltrials.gov) - Jan 21, 2013
P=N/A, N=60, Completed, Sponsor: University of Michigan
N=800 --> 580 Not yet recruiting --> Completed
- Clinical: TreCogAM: Cognitive Remediation Therapy in Anorexia Nervosa (clinicaltrials.gov) - Jan 17, 2013
P=N/A, N=120, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
- ||| Amitiza (lubiprostone) / Takeda, Mallinckrodt
Trial completion, Surgery: Lubiprostone (Amitiza (clinicaltrials.gov) - Jan 16, 2013
P=N/A, N=64, Completed, Sponsor: Rehabilitation Institute of Chicago
Not yet recruiting --> Completed Recruiting --> Completed
- ||||||| Akynzeo oral (netupitant/palonesteron FDC) / Helsinn, Roche, Otsuka, Mundipharma, Immedica
Trial completion: A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting (clinicaltrials.gov) - Jan 15, 2013
P3, N=413, Completed, Sponsor: Helsinn Healthcare SA
Recruiting --> Completed Recruiting --> Completed
- ||||||| Akynzeo oral (netupitant/palonesteron FDC) / Helsinn, Roche, Otsuka, Mundipharma, Immedica
Trial completion, Combination therapy: An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting (clinicaltrials.gov) - Jan 15, 2013
P3, N=1455, Completed, Sponsor: Helsinn Healthcare SA
Recruiting --> Completed Recruiting --> Completed
- | Enrollment open: Acupuncture in Infantile Colic - a Three Armed Randomized Multi Center Trial (ACU-COL) (clinicaltrials.gov) - Jan 10, 2013
P2/3, N=192, Recruiting, Sponsor: Lund University
Recruiting --> Completed Not yet recruiting --> Recruiting
- |||| Decadron (dexamethasone) / Merck (MSD)
Enrollment open, CINV: A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) (clinicaltrials.gov) - Jan 7, 2013
P4, N=492, Recruiting, Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Enrollment closed: Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain (clinicaltrials.gov) - Jan 6, 2013
P=N/A, N=81, Active, not recruiting, Sponsor: Medical College of Wisconsin
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Amitiza (lubiprostone) / Takeda, Mallinckrodt
Enrollment change: Intestinal Microecology in Chronic Constipation (clinicaltrials.gov) - Jan 6, 2013
P1, N=21, Completed, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting N=30 --> 21
- || New P2/3 trial: Acupuncture in Infantile Colic - a Three Armed Randomized Multi Center Trial (ACU-COL) (clinicaltrials.gov) - Jan 2, 2013
P2/3, N=192, Recruiting, Sponsor: Lund University
- Trial withdrawal: Diarrhea and Bivalent Oral Polio Vaccine Immunity (clinicaltrials.gov) - Jan 2, 2013
P3, N=0, Withdrawn, Sponsor: Centers for Disease Control and Prevention
N=30 --> 21 Not yet recruiting --> Withdrawn
- Enrollment change: Diarrhea and Bivalent Oral Polio Vaccine Immunity (clinicaltrials.gov) - Jan 2, 2013
P3, N=0, Withdrawn, Sponsor: Centers for Disease Control and Prevention
Not yet recruiting --> Withdrawn N=900 --> 0
- Trial withdrawal: Adhesiolysis in Chronic Abdominal Pain (clinicaltrials.gov) - Dec 30, 2012
P=N/A, N=0, Withdrawn, Sponsor: North Karelia Central Hospital
N=900 --> 0 Not yet recruiting --> Withdrawn
- Enrollment change: Adhesiolysis in Chronic Abdominal Pain (clinicaltrials.gov) - Dec 30, 2012
P=N/A, N=0, Withdrawn, Sponsor: North Karelia Central Hospital
Not yet recruiting --> Withdrawn N=140 --> 0
- Trial completion: CLONEMESI: Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum (clinicaltrials.gov) - Dec 29, 2012
P3, N=13, Completed, Sponsor: Azienda Ospedaliera Città della Salute e della Scienza di Torino
N=140 --> 0 Recruiting --> Completed
- Enrollment change: ESPNV: Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting (clinicaltrials.gov) - Dec 27, 2012
P4, N=599, Completed, Sponsor: Shanghai Changzheng Hospital
Recruiting --> Completed N=1000 --> 599
- Trial completion: ESPNV: Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting (clinicaltrials.gov) - Dec 27, 2012
P4, N=599, Completed, Sponsor: Shanghai Changzheng Hospital
N=1000 --> 599 Recruiting --> Completed
- | Trial completion, Compliance: Effect of TU-100 on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Females With Constipation (clinicaltrials.gov) - Dec 26, 2012
P1/2, N=45, Completed, Sponsor: Tsumura USA
Recruiting --> Completed Recruiting --> Completed
- Enrollment closed: Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD) (clinicaltrials.gov) - Dec 20, 2012
P=N/A, N=10, Active, not recruiting, Sponsor: Cook
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Amitiza (lubiprostone) / Takeda, Mallinckrodt
Trial initiation date: Lubiprostone Effect on Gastrointestinal (GI) Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation (clinicaltrials.gov) - Dec 15, 2012
P2/3, N=15, Active, not recruiting, Sponsor: Texas Tech University Health Sciences Center
Recruiting --> Active, not recruiting Initiation date: Nov 2011 --> Jun 2012
- | Amitiza (lubiprostone) / Takeda, Mallinckrodt
Enrollment closed: Lubiprostone Effect on Gastrointestinal (GI) Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation (clinicaltrials.gov) - Dec 15, 2012
P2/3, N=15, Active, not recruiting, Sponsor: Texas Tech University Health Sciences Center
Initiation date: Nov 2011 --> Jun 2012 Not yet recruiting --> Active, not recruiting
- Enrollment change: Effects of Acupuncture in the Treatment of Infant Colic (clinicaltrials.gov) - Dec 12, 2012
P2, N=90, Completed, Sponsor: University of Oslo
Not yet recruiting --> Active, not recruiting N=130 --> 90
- Trial completion: Effects of Acupuncture in the Treatment of Infant Colic (clinicaltrials.gov) - Dec 12, 2012
P2, N=90, Completed, Sponsor: University of Oslo
N=130 --> 90 Recruiting --> Completed
- aprepitant oral / Generic mfg., melphalan / Generic mfg.
Trial completion: Treatment of Chemotherapy-induced Nausea and Vomiting (clinicaltrials.gov) - Dec 11, 2012
P2, N=90, Completed, Sponsor: Uppsala University Hospital
Recruiting --> Completed Recruiting --> Completed
- Trial initiation date: Probiotics in Hospitalized Patients Study (clinicaltrials.gov) - Dec 10, 2012
P=N/A, N=600, Not yet recruiting, Sponsor: South Shore Hospital
Recruiting --> Completed Initiation date: Jul 2012 --> Feb 2013
- Trial termination: SacBo: Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea (clinicaltrials.gov) - Dec 9, 2012
P3, N=477, Terminated, Sponsor: Bernhard Nocht Institute for Tropical Medicine
Initiation date: Jul 2012 --> Feb 2013 Recruiting --> Terminated; Masked independent interim analysis: completion of the trial was unlikely.
- Enrollment change: SacBo: Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea (clinicaltrials.gov) - Dec 9, 2012
P3, N=477, Terminated, Sponsor: Bernhard Nocht Institute for Tropical Medicine
Recruiting --> Terminated; Masked independent interim analysis: completion of the trial was unlikely. N=1520 --> 477
- ||||| Movantik (naloxegol) / AstraZeneca, RedHill, Kyowa Kirin
Enrollment change: Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation (clinicaltrials.gov) - Dec 9, 2012
P3, N=844, Completed, Sponsor: AstraZeneca
N=1520 --> 477 N=1135 --> 844